A woman holds a small bottle labeled with a “Coronavirus COVID-19 Vaccine” sticker and a medical syringe in front of displayed Pfizer logo in this illustration taken, October 30, 2020.
Dado Ruvic | Reuters
Pfizer on Tuesday reported $3.5 billion in first-quarter sales of its Covid-19 vaccine with German drugmaker BioNTech.
In releasing its first-quarter financial results, the company also reported earnings and revenue that beat Wall Street’s expectations.
Here’s how Pfizer did compared with what Wall Street expected, according to average estimates compiled by Refinitiv:
- Adjusted EPS: 93 cents per share vs 77 cents expected
- Revenue: $14.58 billion vs. $13.51 billion expected
This is a developing story. Please check back for updates.